A 59-year-old woman has filed suit against Merck for allegedly withholding warnings that the osteoporosis drug Fosamax can cause jawbone tissue death. The lawsuit seeks to represent more than 10 million Fosamax users. A spokesman for Merck said jawbone tissue death is an "exceedingly rare" side effect and a warning was already added to the label back in July 2005. Bloomberg News, LA Times 04/13/2006 Read Article: LA Times
Thursday, April 13, 2006
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment